IBDEI15K ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19254,1,3,0)
 ;;=3^Fatty Liver NEC
 ;;^UTILITY(U,$J,358.3,19254,1,4,0)
 ;;=4^K76.0
 ;;^UTILITY(U,$J,358.3,19254,2)
 ;;=^5008831
 ;;^UTILITY(U,$J,358.3,19255,0)
 ;;=K76.89^^94^919^18
 ;;^UTILITY(U,$J,358.3,19255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19255,1,3,0)
 ;;=3^Liver Disease NEC
 ;;^UTILITY(U,$J,358.3,19255,1,4,0)
 ;;=4^K76.89
 ;;^UTILITY(U,$J,358.3,19255,2)
 ;;=^5008835
 ;;^UTILITY(U,$J,358.3,19256,0)
 ;;=K71.6^^94^919^32
 ;;^UTILITY(U,$J,358.3,19256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19256,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,19256,1,4,0)
 ;;=4^K71.6
 ;;^UTILITY(U,$J,358.3,19256,2)
 ;;=^5008801
 ;;^UTILITY(U,$J,358.3,19257,0)
 ;;=K75.9^^94^919^17
 ;;^UTILITY(U,$J,358.3,19257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19257,1,3,0)
 ;;=3^Inflammatory Liver Disease,Unspec
 ;;^UTILITY(U,$J,358.3,19257,1,4,0)
 ;;=4^K75.9
 ;;^UTILITY(U,$J,358.3,19257,2)
 ;;=^5008830
 ;;^UTILITY(U,$J,358.3,19258,0)
 ;;=K71.0^^94^919^24
 ;;^UTILITY(U,$J,358.3,19258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19258,1,3,0)
 ;;=3^Toxic Liver Disease w/ Cholestasis
 ;;^UTILITY(U,$J,358.3,19258,1,4,0)
 ;;=4^K71.0
 ;;^UTILITY(U,$J,358.3,19258,2)
 ;;=^5008793
 ;;^UTILITY(U,$J,358.3,19259,0)
 ;;=K71.10^^94^919^30
 ;;^UTILITY(U,$J,358.3,19259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19259,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/o Coma
 ;;^UTILITY(U,$J,358.3,19259,1,4,0)
 ;;=4^K71.10
 ;;^UTILITY(U,$J,358.3,19259,2)
 ;;=^5008794
 ;;^UTILITY(U,$J,358.3,19260,0)
 ;;=K71.11^^94^919^31
 ;;^UTILITY(U,$J,358.3,19260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19260,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/ Coma
 ;;^UTILITY(U,$J,358.3,19260,1,4,0)
 ;;=4^K71.11
 ;;^UTILITY(U,$J,358.3,19260,2)
 ;;=^5008795
 ;;^UTILITY(U,$J,358.3,19261,0)
 ;;=K71.2^^94^919^23
 ;;^UTILITY(U,$J,358.3,19261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19261,1,3,0)
 ;;=3^Toxic Liver Disease w/ Acute Hepatitis
 ;;^UTILITY(U,$J,358.3,19261,1,4,0)
 ;;=4^K71.2
 ;;^UTILITY(U,$J,358.3,19261,2)
 ;;=^5008796
 ;;^UTILITY(U,$J,358.3,19262,0)
 ;;=K71.3^^94^919^28
 ;;^UTILITY(U,$J,358.3,19262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19262,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Persistent Hepatitis
 ;;^UTILITY(U,$J,358.3,19262,1,4,0)
 ;;=4^K71.3
 ;;^UTILITY(U,$J,358.3,19262,2)
 ;;=^5008797
 ;;^UTILITY(U,$J,358.3,19263,0)
 ;;=K71.4^^94^919^27
 ;;^UTILITY(U,$J,358.3,19263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19263,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Lobular Hepatitis
 ;;^UTILITY(U,$J,358.3,19263,1,4,0)
 ;;=4^K71.4
 ;;^UTILITY(U,$J,358.3,19263,2)
 ;;=^5008798
 ;;^UTILITY(U,$J,358.3,19264,0)
 ;;=K75.81^^94^919^19
 ;;^UTILITY(U,$J,358.3,19264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19264,1,3,0)
 ;;=3^Nonalcoholic Steatohepatitis (NASH)
 ;;^UTILITY(U,$J,358.3,19264,1,4,0)
 ;;=4^K75.81
 ;;^UTILITY(U,$J,358.3,19264,2)
 ;;=^5008828
 ;;^UTILITY(U,$J,358.3,19265,0)
 ;;=K75.89^^94^919^16
 ;;^UTILITY(U,$J,358.3,19265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19265,1,3,0)
 ;;=3^Inflammatory Liver Disease,Oth Spec
 ;;^UTILITY(U,$J,358.3,19265,1,4,0)
 ;;=4^K75.89
 ;;^UTILITY(U,$J,358.3,19265,2)
 ;;=^5008829
 ;;^UTILITY(U,$J,358.3,19266,0)
 ;;=K76.4^^94^919^21
 ;;^UTILITY(U,$J,358.3,19266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19266,1,3,0)
 ;;=3^Peliosis Hepatis
 ;;^UTILITY(U,$J,358.3,19266,1,4,0)
 ;;=4^K76.4
 ;;^UTILITY(U,$J,358.3,19266,2)
 ;;=^91041
 ;;^UTILITY(U,$J,358.3,19267,0)
 ;;=K71.50^^94^919^25
